Sort
78,016 grants matching “breast cancer”
Enabling clinical tissue microstructure imaging as a diagnostic tool in wide-bore 3T MRI
$1,067,677Thomas K Foo · Ge Medical Systems Information Technologies, Inc · U01 · FY2025 · EB
Transplant Models
$1,067,628Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
TARGETING THE S1P AXIS AND DEVELOPMENT OF A NOVEL THERAPY FOR OBESITY-RELATED TRIPLE NEGATIVE BREAST CANCER
$1,067,486Virginia Commonwealth University · · FY2014 · Department of Defense
First-in-Class CD206 Agonist for Immunologically Cold Solid Organ Cancers
$1,066,904Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Developing Therapeutic Candidates for Rare ADCK3-amplified Cancers
$1,066,904Wenwei Huang · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
TUMORS EFFECTS ON THE SKELETON
$1,066,848University Of Texas Hlth Sci Ctr San Ant · P01 · FY2000 · CA
Repository Services for epidemiology studies
$1,066,827Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
Biostatistics and Data Management
$1,066,777Kathryn L Lunetta · Roswell Park Cancer Institute Corp · P01 · FY2012 · CA
Evaluation of Multi Modality Breast Imaging
$1,066,400Mitchell D Schnall · University Of Pennsylvania · P01 · FY2006 · CA
A RESOURCE FOR MAGNETIC RESONANCE AND OPTICAL RESEARCH
$1,065,955University Of Pennsylvania · P41 · FY2001 · RR
Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic
$1,065,864Lynn C. Hartmann · Mayo Clinic Rochester · K12 · FY2008 · CA
Detroit Research on Cancer Survivors (Detroit ROCS)
$1,065,093Ann G Schwartz · Wayne State University · U01 · FY2025 · CA
Texas Center for Minority Health, Education, Research and Outreach
$1,064,981Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · U54 · FY2018 · MD
Cell-Surface Interactions in Pathogenesis
$1,064,783Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE
Investigate the DNA damage response pathway of Fanconi anemia and BRCA proteins
$1,064,527Weidong Wang · Aging · Z01 · FY2007 · AG
SAFE AND EFFECTIVE TARGETING OF BREAST CANCER PROGENITOR CELLS WITH A NOTCH 3 ANTIBODY-DRUG CONJUGATE
$1,064,427University Of California, Los Angeles · · FY2014 · Department of Defense
Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - CCC (Lead)
$1,064,328Steven M Kawut · University Of Pennsylvania · R01 · FY2021 · HL
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
$1,063,219Michael J Thun · American Cancer Society, Inc. · U01 · FY2008 · CA
PPAR ALPHA AND FENOFIBRATE FOR THE PREVENTION OR TREATMENT OF BREAST CANCER BRAIN METASTASIS
$1,063,190Wake Forest University Health Sciences · · FY2020 · Defense Health Agency
Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain
$1,063,128Lauren Jennifer Schwimmer · Abalone Bio, Inc. · R44 · FY2022 · CA
Novel small molecules for protection against doxorubicin cardiotoxicity in TNBC
$1,062,913Cathy A Swindlehurst · Novomedix, Inc. · R44 · FY2022 · HL
Case Comprehensive Cancer Center (Case CCC) Cancer Health Disparities SPORE Planning Grant
$1,062,400Nathan A. Berger · Case Western Reserve University · P20 · FY2018 · CA
University of Pennsylvania Patient-derived Xenograft Development and Trials Center
$1,062,215Martin Carroll · University Of Pennsylvania · U54 · FY2025 · CA
Environmental and Genetic Determinants of Puberty
$1,062,186Mary S Wolff · Icahn School Of Medicine At Mount Sinai · U01 · FY2013 · ES
Pharmacology & human Phase 1 safety & dose escalation studies using anti-GP88 in aggressive breast cancer
$1,062,115Ginette Serrero · A And G Pharmaceutical, Inc. · R44 · FY2020 · CA